Metropolis Healthcare acquires Shraddha Diagnostics

Metropolis Healthcare acquires Shraddha Diagnostics

The diagnostics company Metropolis Healthcare has signed an agreement to acquire Ahmedabad based Shraddha Diagnostics, expanding its laboratory chain from 17 to 20 cities.

With the acquisition, Metropolis widens to towns of Gujarat: Ahmedabad, Surat, Baroda, Mehsana, Rajkot, Navsari, Jamnagar, Bharuch and Gandhidham.

The company currently has 300 patient service network centers across Gujarat. The company offers a range of 3,487 clinical laboratory tests and 530 profiles that includes advanced tests in the diagnosis of cancer, neurological disorders, infectious diseases and an array of genetic abnormalities.

“With the Ahmedabad acquisition, Metropolis aims to gain profitable market share by building better leadership, operational capabilities, and expanding our test menu. Our immediate focus would be to fully integrate and modernize these laboratories and in terms of diagnosis, deliver on our promise of integrity, empathy, and accuracy,” said Ameera Shah, Promoter and Managing Director, Metropolis Healthcare, in a statement.

Straight Talk